Ureaplasma urealyticum (U. urealyticum)

Ureaplasma urealyticum is a species of small, cell wall-deficient bacteria belonging to the class Mollicutes and the family Mycoplasmataceae (Wikipedia, 2024; Medscape, 2025). It is a common inhabitant of the human urogenital tract, where it can exist as a commensal or an opportunistic pathogen associated with conditions such as non-gonococcal urethritis, pelvic inflammatory disease, and adverse pregnancy outcomes including preterm birth and neonatal respiratory disease (Medscape, 2025; Medical News Today, 2024). A unique metabolic hallmark of this organism is its reliance on urea hydrolysis via the enzyme urease to generate ammonia and drive ATP synthesis, a process that also contributes to its pathogenicity (PMC, 2024; PubMed, 1993). Because it lacks a peptidoglycan cell wall, U. urealyticum is intrinsically resistant to beta-lactam antibiotics and glycopeptides, requiring treatment with macrolides, tetracyclines, or fluoroquinolones that target internal bacterial processes like protein synthesis or DNA replication (Wikipedia, 2024; Medscape, 2025). The increasing prevalence of acquired resistance to these antibiotic classes represents a significant therapeutic challenge in clinical practice (Journal of Antimicrobial Chemotherapy, 2016).

Other names

T-strain mycoplasmaUreaplasma species

Inhibition of bacterial protein synthesis via binding to the 30S or 50S ribosomal subunits, or inhibition of DNA replication via targeting DNA gyrase and topoisomerase IV.